Glucagon-like peptide-1 receptor agonists and mental health: a narrative review of emerging benefits and risks
{{output}}
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus and obesity, are increasingly recognized for their significant impact on the central nervous system, leading to reports of both beneficial and adverse ment... ...
